London – Researchers found in their new study, published in the New England Journal of Medicine, that Ozempic or Wegovy, drug used for weight loss — semaglutide — might contribute to reducing or completely cutting the insulin shots in people diagnosed with Type 1 diabetes. They analysed information from 10 people with Type 1 diabetes who took the drug. who stopped taking insulin shots with meals and in six months, 7 out of 10 completely stopped using insulin.